User:Bawolff/Edit COI Summary/10 per page (newest first)/32

Cannot transclude talk pages due to post expand include size limit. Please visit individual talk pages to see the discussion.

• GenScript Biotech
• REDMAP
• PennyMac Financial Services
• Salutem Healthcare
• Thymosin beta-4
• Egged (company)
• Ian Darling
• Function Health
• Iraqi Jewish Archive
• Danna Azrieli

---

← Previous page Next page→

GenScript Biotech

13 May 2026 edit request

Hello Wikipedia, my name is Melis and I would like to present a suggestion for this article. Currently, it only has a History section in addition to the normal lead and infobox. The sources used need to be updated generally to remove the old archive links and there are several instances of poor sourcing, including MarketScreener, a Forbes contributor piece, several press releases.

I would like to present editors with an updated version of this article in my User space. For easy review, here is a diff between my proposal and the current article.

My proposal updates the sources when possible and adds news sections including Operations, Production, and Research. Some of the information in the History section was moved to the more appropriate section.

I would love to hear any feedback editors may have. Thank you! Melis for GenScript (talk) 22:18, 13 May 2026 (UTC)

Hi Melis for GenScript, thank you for proposed changes to the article. It helped me identify vandalism that had been unfixed in the article for months. However, it is quite difficult to assess wholesale article changes in a userspace article draft, and even though there is a diff included, it makes it hard to see specific section-by-section changes. For example, your draft of the article removes information currently in the article such as "In 2004, it set up a research and production base in Nanjing, China." and "In 2015, GenScript went public on the SEHK." without offering rationale for why this information should be removed. If you had something section-by-section (e.g. lead, infobox, history, etc.) highlighting removals, changes, and additions with rationale, it would make it much easier for impartial editors to review this request rather than having to closely scrutinize which information may have been removed without clear explanation. Best, Spencer^T•C 22:27, 24 May 2026 (UTC)

I understand! Let someone close out the request and I will post a smaller request in a new section below. Thanks! Melis for GenScript (talk) 05:50, 28 May 2026 (UTC)

Operations section

Per User:Spencer's request, I have taken the diff above and broken out a smaller request from it. I would like to focus on the proposed Operations section first, since it is all additions.

Draft:

GenScript is headquartered in Piscataway, New Jersey. It established presences in the United States, China, Singapore, Japan, the United Kingdom, and the Netherlands, among others.

GenScript's operations are divided into life-science services and products, biologics CDMO, and industrial enzymes.

The company was founded by Frank Zhang, Sally Wang, and Larry Wang. As of 2026, leadership included Robin Meng, chairman; Sherry Shao, rotating CEO; and Ray Chen, Life Science Group president. Its scientific advisory board includes George Church, Carl June, and David R. Liu, as of 2026.

GenScript has operations in over 100 countries and over 250,000 customers, as of 2025. That year, its revenue was $959.5 million and it had over 6,165 employees.

References

I will propose subsections for this in the future if it is accepted, but those borrow from current content so I wanted to present something entirely new for editors to consider. Thanks! Melis for GenScript (talk) 05:50, 28 May 2026 (UTC)

The U.S. subsidiary is based in New Jersey, not the parent company. This article is about the parent company. - Amigao (talk) 20:25, 28 May 2026 (UTC)

@Amigao: I see what you mean. What about phrasing such as, "GenScript has principal offices in Nanjing, China and Piscataway, New Jersey"?

Let me know what you think! Melis for GenScript (talk) 21:07, 10 June 2026 (UTC)

That is not very clear. The parent company is headquartered in China, which is the topic of this article. The New Jersey operations are run by the U.S. subsidiary. - Amigao (talk) 21:12, 10 June 2026 (UTC)

@Amigao: I understand. Do you have any thoughts about the rest of the proposal? Perhaps for now it is best to omit this sentence entirely and focus on just the Operations section addition and the rest of the content. Melis for GenScript (talk) 21:58, 15 June 2026 (UTC)

Omitting that fact would then paint a less complete and clear picture. Why would we want to remove where the parent company is based? - Amigao (talk) 02:01, 16 June 2026 (UTC)

@Amigao: I understand. Would you be willing to consider the draft below, which revises the first sentence of my proposal?

Draft:

GenScript Biotech Corporation is headquartered in Nanjing, China. It established presences in the United States, China, Singapore, Japan, the United Kingdom, and the Netherlands, among others.

GenScript's operations are divided into life-science services and products, biologics CDMO, and industrial enzymes.

The company was founded by Frank Zhang, Sally Wang, and Larry Wang. As of 2026, leadership included Robin Meng, chairman; Sherry Shao, rotating CEO; and Ray Chen, Life Science Group president. Its scientific advisory board includes George Church, Carl June, and David R. Liu, as of 2026.

GenScript has operations in over 100 countries and over 250,000 customers, as of 2025. That year, its revenue was $959.5 million and it had over 6,165 employees.

References

Let me know if this is better Melis for GenScript (talk) 21:32, 30 June 2026 (UTC)

REDMAP

Conflict of interest edit request: clarify Maptitude wording in lead

Disclosure: I have a professional affiliation with Caliper Corporation / Maptitude, so I am not making this edit directly. I am requesting review by an uninvolved editor.

Summary of request: Please revise the article's wording about redistricting software. The current lead describes Caliper Corporation's Maptitude as "previously unavailable" mapping software used by REDMAP. That phrasing is unsupported, over-specific for the lead, and misleading in context. Independent sources describe Maptitude for Redistricting as a widely used redistricting platform, including by state legislatures, political parties, government bodies, commissions, and nonpartisan redistricting projects. A more neutral summary would describe the role of voter data, computerized models, and redistricting software generally in the lead, with a more precise, sourced discussion of Maptitude in the body.

Requested change 1: Lead

Please replace this sentence in the lead:

"The project has made effective use of partisan gerrymandering by relying on previously unavailable mapping software, such as Caliper Corporation's Maptitude to improve the precision with which district lines are strategically drawn."

with:

"The project has made effective use of partisan gerrymandering following Republican gains in state legislatures during the 2010 elections, which gave the party control over post-Census redistricting in key states. Advances in voter data, computerized redistricting models, and redistricting software allowed mapmakers to draw districts with greater precision."

Requested change 2: Effects section

Please replace this sentence in the Effects section:

"They then used sophisticated software such as Maptitude for Redistricting, the software used by most entities, independent commissions, and political parties involved in redistricting, to devise districts favorable to the Republican party, for example by clustering Democratic voters into a handful of districts and ensuring the rest were drawn to include Republican majorities."

with:

"They then used computerized redistricting models and redistricting software, including Maptitude for Redistricting, to devise districts favorable to the Republican Party, for example by clustering Democratic voters into a handful of districts and ensuring the rest were drawn to include Republican majorities. Maptitude for Redistricting was also widely used outside REDMAP; Roll Call described it as dominant in the redistricting software market, with users including a majority of state legislatures, national party committees, the Justice Department's Civil Rights Division, and the Arizona Independent Redistricting Commission. The Redistricting Data Hub, a nonpartisan redistricting data project, has also listed Maptitude among the redistricting software used by numerous states. Maptitude was also used in nonpartisan redistricting work, including Columbia Law School's DrawCongress.org project, which sought to create nonpartisan congressional maps for all 435 congressional districts."

Reason: The current wording says REDMAP relied on "previously unavailable" mapping software, naming Maptitude in the lead. That phrasing is not supported by the sources and gives undue emphasis to one software product in the article summary. The better-supported lead point is broader: after the 2010 elections, Republicans controlled redistricting in key states, and modern voter data, computerized models, and redistricting software made district drawing more precise.

The Maptitude-specific point is better handled in the Effects section, where it can be described with independent sources. The Guardian reports that Caliper rolled out its first version of Maptitude for redistricting in the 1990s, so "previously unavailable" is not an accurate description of the software in the 2010 redistricting cycle. Roll Call describes Maptitude for Redistricting as dominant in the redistricting software market and identifies users including a majority of state legislatures, national party committees, the Justice Department's Civil Rights Division, and the Arizona Independent Redistricting Commission. The Redistricting Data Hub lists Maptitude as software used by many state redistricting bodies. The University of Chicago Library documents use of Maptitude for Columbia Law School's nonpartisan DrawCongress.org project. The U.S. News sources support the surrounding REDMAP context, including the use of computerized models after 2010 and the fact that users can plug their own data into Maptitude.

These changes preserve the article's point that REDMAP benefited from technology-assisted redistricting, while avoiding an unsupported implication that Maptitude was newly available, unique to REDMAP, or inherently partisan.

References to add or update:

Thank you. ~2026-28869-53 (talk) 18:40, 13 May 2026 (UTC) ~2026-28869-53 (talk) 18:40, 13 May 2026 (UTC)

So one of these sources may be problematic, or worth finding substitutions for if any exist.

• - opinion WP:RS

Seeing as this may be considered a COIN edit, you might have more luck with this request at the WP:TEAHOUSE. Cheers. DN (talk) 02:38, 27 May 2026 (UTC)

References

PennyMac Financial Services

Page updates

Hello, much of this page reflects data from 2020. I have already made some edits to the infobox to bring things up to date. In addition, I am requesting the following changes to the second paragraph of the lead:

Please replace the first sentence of this paragraph with:

• In 2025, Pennymac was the top correspondent platform, the third overall mortgage lender in the United States, and a top five primary mortgage servicer.

Please replace the second sentence of this paragraph with:

• In its production segment, the company conducts its business through three main channels: correspondent lending, third-party originations, and consumer-direct.

References

Thanks for your help, HomeWithAYard (talk) 17:53, 13 May 2026 (UTC)

• Comment: There is a problem with your citations. The three in support of your first proposed amendment are from the same source, Inside Mortgage Finance, which seemingly charges a not insignificant fee for each piece of the pertinent information. I'd suggest a better string of sources, such as this, this, and this. The suggested new text is in an acceptable direction, though it should reflect explicitly what's in these sources and no more.

The single source cited for the second proposed amendment comes directly from the article's subject itself. That is, as you probably already know, frowned upon but not unacceptable, as the case is here, the way I see it: publicly traded American corporations' financial reports are typically reliable. (That includes reports by corporations with only subsidiaries being publicly traded.) So, as a source, it should be acceptable provided the article only uses information that is explicitly cited in said report; not assessments, reviews, criticism, etc, since any such would be original work done by the contributor and reflecting their views. So, the second amendment is, on the basis of the source proffered, unacceptable. In fact, the sentence as is right now, before any changes, is unsupported by WP-mandated sources and should be stricken off if the problem is not fixed. (If you find reputable, third-party sources supporting what the sentence says, the text would be fine provided we add the word "reportedly".) -The Gnome (talk) 20:03, 3 June 2026 (UTC)

Thanks for your feedback, The Gnome. How would you feel about adding the following, which includes precise wording based on the reputable sources that you suggested?:

• In 2025, Pennymac was named the top overall mortgage lender and top correspondent lender by Scotsman Guide,and ranked fourth among the largest U.S. mortgage lenders by direct loan origination volume according to Bankrate and CNBC.
• In its production segment, the company conducts its business through three main channels: correspondent lending, broker direct, and consumer direct.

References

Thanks, HomeWithAYard (talk) 20:55, 23 June 2026 (UTC)

Greetings. The suggested text reads dry and well. -The Gnome (talk) 09:10, 2 July 2026 (UTC)

Salutem Healthcare

Requested update: Company name, infobox and article content

• What I think should be changed (include citations):

1. Rename the article from Salutem Health Care to Salutem Care and Education.

Evidence for current name usage: - The organisation’s official website clearly uses the name “Salutem Care and Education”. - Independent business profiles and directories also list the organisation as “Salutem Care and Education”. - Professional listings (e.g. LinkedIn) show the current operating name as “Salutem Care and Education”. - Independent care-sector news refers to the organisation as “Salutem Care and Education” in its reporting. - Regional news coverage also uses the name “Salutem Care and Education” when reporting on the organisation’s services.

2. Update the infobox to:

Salutem Care and Education

Type	Private
Industry	Social Care, Special Education
Founded	2016 (2016)
Headquarters	Windsor , United Kingdom
Area served	England and Wales
Key people	John Godden MBE (Chief Executive Officer)
Website	https://www.salutemcareandeducation.co.uk/

3. Replace or update the lead and article content with the following neutral, factual version:

{{short description|UK social care company}}

Salutem Care and Education is a privately held provider of specialist social care, education, and supported living services for children and adults with complex needs, including learning disabilities, autism, and mental health conditions. The organisation operates across England and Wales and is headquartered in Windsor.

History

The organisation was founded in 2016 and has grown through acquisitions and service expansion.

Services

Salutem Care and Education provides a range of services including:

• Adult residential care and supported living
• Children’s residential services
• Specialist education for individuals with Special Educational Needs and Disabilities (SEND)
• Community-based and supported living services

Organisation

The organisation employs several thousand staff across England and Wales.

Regulation

Services are regulated by statutory bodies in England and Wales, including the Care Quality Commission (CQC) and Ofsted.

See also

• Social care in the United Kingdom

References

4. Add reliable sources confirming: - The organisation’s current name - Its services and operations - Leadership and structure

Why it should be changed:

The organisation is currently operating publicly under the name “Salutem Care and Education”, as evidenced by its official website and third‑party business listings. Updating the article would ensure Wikipedia reflects the organisation’s current and commonly used name.

I am suggesting these edits via the talk page in line with Wikipedia’s guidance on conflict of interest and request that an independent editor review and implement them.

Yasmin Skinner (talk) 14:59, 13 May 2026 (UTC)

References

Thymosin beta-4

Edit request: TB-500 vs full thymosin beta-4 clarification (Doping in sports section)

COI disclosure: I have a conflict of interest as the founder of NextPep, a peptide research and comparison platform. I'm filing this Edit Request rather than editing directly. Full disclosure at User:Karl Vorwerg.

I made a related direct edit to this article on 2026-05-12, which was reverted by another editor following the COI notice SmartSE posted on my Talk page. I accept that revert as appropriate given my COI, and I'm refiling the substance of that change here through the proper channel so an uninvolved editor can evaluate the content on its merits.

Proposed addition

In the Doping in sports section, the first paragraph currently reads:

Thymosin beta-4 is considered a performance-enhancing substance and is banned in sports by the World Anti-Doping Agency due to its effect of aiding soft tissue recovery and enabling higher training loads. It was central to two controversies in Australia in the 2010s...

I propose inserting one sentence between the existing first and second sentence:

...higher training loads. The synthetic peptide marketed and detected as "TB-500" under WADA's monitoring program is a seven-amino-acid fragment (LKKTETQ; residues 17–23 of full Tβ4; molecular weight ~889 Da) corresponding to the minimal actin-binding motif of the parent 43-residue protein, although the term is commonly used interchangeably with full-length thymosin beta-4 in the research-peptide and doping-control literature. It was central to two controversies...

Why this improves the article

The article already cites Ho et al. 2012, whose title is literally "Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma..." — the fragment distinction is in the citation title but not in the body text. A reader who doesn't click the reference doesn't learn that "TB-500" and "thymosin beta-4" refer to different molecules. The Doping section uses both terms interchangeably, which leaves the basic factual distinction inaccessible to a general reader.

Van Troys et al. 1996 (PMID 8670856) established that residues 17–23 of Tβ4 constitute the minimal actin-binding motif, which is exactly the sequence that synthetic "TB-500" replicates.

Sources

Both already available — no new sources are strictly required for the proposed sentence:

• Ho EN, Kwok WH, Lau MY, Wong AS, Wan TS, Lam KK, Schiff PJ, Stewart BD (November 2012). "Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma by liquid chromatography-mass spectrometry". Journal of Chromatography A. 1265: 57–69. doi:10.1016/j.chroma.2012.09.043. PMID 23084823. (already cited in the article as the third reference in the Doping in sports section)
• Van Troys M, Dewitte D, Goethals M, Carlier MF, Vandekerckhove J, Ampe C (1996). "The actin binding site of thymosin beta 4, mapped by mutational analysis". The EMBO Journal. 15 (2): 201–210. doi:10.1002/j.1460-2075.1996.tb00350.x. PMID 8670856.

Optional supplementary source

A secondary explainer synthesising the fragment-vs-protein distinction for general readers exists at https://nextpep.app/blog/tb-500-vs-thymosin-beta-4 . I authored this; I'm disclosing the COI here and noting that the proposed clarification stands on the two primary sources above without it. Whether to include the secondary source as an additional citation is entirely at the reviewing editor's discretion — either outcome is acceptable to me, and I will not contest the decision.

Thank you for the review.

Karl Vorwerg (talk) 12:37, 12 May 2026 (UTC)

Egged (company)

Edit request 12 May 2026

This article needs some updating as Egged changed ownership and expanded its activities. General note regarding the data: the numbers of buses, employees, etc., vary from article to article, so I used the most up-to-date references for each number.

Please replace the second sentence in the lede with the following:

It also operates buses in Poland, the Netherlands and Lithuania through a subsidiary and Tel Aviv’s light rail Red Line via Tevel.

Replace the second paragraph in the lede with the following, in order to update the company’s numbers and its ownership:

Egged provides about 35% of Israel's public transport services, employs approximately 11,500 workers worldwide (8,000 in Israel and 3,500 in Europe) and operates a fleet of approximately 3,200 buses in Israel, and more than 1,200 additional buses in Europe through its subsidiaries.

In 2021, Egged was considered the fifth-largest bus company in the world.

In 2022, a controlling stake in Egged was acquired by Keystone, an Israeli publicly traded infrastructure investment fund, with the remainder held by the teachers' pension funds and veteran members. As of January 2026, Keystone and the teachers' pension funds hold 91% of Egged.

Delete the second sentence in the fifth paragraph in the History heading, starting with “Had its members voted to not convert its ownership structure…” as that’s an old and irrelevant statement.

Add the following text at the end of the history heading(and before the sub-heading A history of attacks):

Since 2022, shares of Egged have been acquired by a partnership between Keystone and the Teachers and Kindergarten Teachers Fund in three stages:

First stage: Carried out in October 2022, during which 60% of Egged’s shares were purchased by the partnership of Keystone Fund and the Teachers and Kindergarten Teachers Fund for approximately NIS 3 billion. After this stage, Keystone held about 48% of the partnership, and the Teachers and Kindergarten Teachers Fund held about 12%.

Second stage: In February 2025, an additional 18% of Egged’s shares were acquired by the partnership for approximately NIS 833 million, bringing their total holdings in the company to 78%.

Third stage: In January 2026, the partnership completed the purchase of a further 13.2% of Egged’s shares for NIS 600 million, raising its holdings in the company to 91.4%.

In January 2026, Egged Group unveiled a new brand identity, replacing its iconic green livery with blue. The rebranding, executed under the tagline 'Not Just a Bus Operator', reflects the company's evolution from a bus cooperative into a diversified transportation group operating buses, light rail, private shuttles, real estate, and international services in Europe.

Please add a new heading after History:

Subsidiaries

• Egged Buses – operates around 3,200 buses in Israel.
• Derech Egged – Operates public transportation services in the Jerusalem metropolitan area. The company began operations in 2024.
• Egged Golan – Since October 2025, Egged Golan ( jointly owned by Egged and the Golan Regional Council) has been operating public transportation in the Golan Heights.
• EBS: operates a fleet of approximately 720 buses in the Netherlands.
• Mobilis: operates around 400 buses in Poland.
• TOKS: operates 140 buses in Lithuania.
• Egged Garage: services buses in more than 20 garages throughout Israel.
• Egged Plus: operates approximately 300 buses for private and educational transport.
• Egged Metro: responsible for the green and purple lines (both under construction) of Tel Aviv’s Light Rail.
• Tevel: Operates the Red Line of Tel Aviv’s Light Rail.
• Egged Real Estate: managing and developing the land and assets owned by the group.
• Drive Group: partly owned by Egged, Drive Group operated Israel’s main toll roads like Highway 6 and HaCarmel Lanes.
• Egged Leasing: offers operating lease for buses and mini-buses.

Replace the second and third sentences in the International ventures heading with the following (since Egged’s operation in Bulgaria was discontinued, they are irrelevant):

Trans-Triumph repurchased its shares in 2008 and Egged has not operated in Bulgaria since then.

Replace the second paragraph in the International ventures heading with the following, which updates Egged's activity in Poland:

Egged operates some 400 buses in Poland, where it owns the Polish bus company Mobilis, which it acquired for €4 million in 2006. The company employs around 1,000 people. Mobilis operates metropolitan bus routes in Warsaw, Kraków and Wrocław, making it the largest private public transport operator in Warsaw and the only private operator in Kraków.

Replace the third paragraph of the International ventures heading with the following, which updates Egged's activity in the Netherlands (there’s already a heading about criticism, so there is no need to duplicate here the opposition to a specific old contract):

Egged Bus Services (EBS) won a contract for public transport in the region Waterland in the Netherlands, starting December 2011. EBS later won a new ten-year contract (extendable by five years) for operating the buses in the Zaanstreek-Waterland area from 2023.

In December 2017, the Rotterdam-The Hague Metropolitan Region (MRDH) awarded EBS the public transport concession for the Voorne-Putten region, south of Rotterdam, which commenced service in December 2018. In July 2018, EBS was awarded the Haaglanden regional bus concession (surrounding The Hague), commencing operations in August 2019 for a period of 11.5 years.

In March 2025, EBS won the tender to operate public transport in the Province of Zeeland in southwest Netherlands. The concession involves approximately 120 buses (90 of which will be electric) operating from five depots.

As of 2025, EBS operates a fleet of approximately 720 buses across four concession areas in the Netherlands, the majority of which are electric or gas-powered. The company employs around 2,200 people and has consistently been ranked highest in passenger satisfaction among Dutch public transport operators.

Please add this paragraph, regarding Egged's activity in Lithuania, at the end of the International ventures heading:

In 2025 Egged purchased 51% of the Lithuanian Toks bus company, which runs services to and in Vilnius and Klaipėda. The company operates 140 buses and employs around 500 people.

Please add a new heading after the "Mehadrin" routes heading:

Other special routes

Night lines

Since 2007, Egged has operated night bus lines in the metropolitan areas of Jerusalem and Haifa, as well as from Tel Aviv to several cities in the Gush Dan region. The night lines operate year-round on Thursday–Friday nights and Saturday–Sunday nights.

TikTak

In 2020, Egged launched a fleet of minibuses in Haifa and Jerusalem, in collaboration with Via, using technology developed by Via. The service was discontinued in 2023.

Route to Cairo

In 1982, Egged began operating Route 100, which connected Tel Aviv and Cairo. The route gradually declined due to lack of profitability and was ultimately discontinued in 1996.

Please add a new heading after the Other special routes heading:

Derech Egged

In 2024, Egged established a wholly-owned subsidiary called Derech Egged (lit. Egged's Way) to operate bus services in the Western Jerusalem Envelope cluster. In its first year, the company served approximately 5.5 million passengers using a fleet of over 300 new buses.

Please update the Infobox as follows (most data is already referenced in the lede):

new line: Company type: Limited (Ltd)

update the parent line to: Keystone Fund and Teachers and Kindergarten Teachers Fund (91.4%)

update the Employees number to: 11,500

add another line to the service area: Lithuania

update the fleet line: 3,200 (Israel), 1,200 (Europe)

update the Daily rideship line: 1,000,000 (Israel)

update annual rideship to: 320,000,000 (Israel)

new line: Key people: Amir Levy (Chairman), Gilad Riklin (CEO)

References

Adig-pt (talk) 06:46, 12 May 2026 (UTC)

Ian Darling

Edit request: rewrite article to address résumé-style tone

Please replace the current article wikitext in full, from the opening line beginning

through the final category line , with the replacement wikitext below.

Extended content

After applying the replacement text, please remove from the maintenance template if you agree the rewritten article no longer reads like a résumé. I am not requesting direct removal of the COI tag unless an uninvolved editor determines it is appropriate.

I have a conflict of interest with this article, so I am not making the change directly. I am requesting review by an uninvolved editor.

The article is currently tagged as being written like a résumé and as having possible COI issues. I have prepared a proposed rewrite below that:

• removes first-paragraph résumé/list structure;
• reduces promotional and evaluative phrasing;
• consolidates biographical material into prose;
• keeps factual claims tied to the existing citations;
• removes some unsourced or weakly sourced detail;
• preserves the filmography, awards and honours sections in a more neutral format.

If an uninvolved editor considers the rewrite acceptable, could they please replace the article text with the version below and consider whether the résumé-style tag can be removed? I understand that the COI tag should remain or be removed only at the discretion of uninvolved editors.

Proposed replacement article text

For the British judge, see Ian Darling (judge).

Ian Darling AO
Born	Melbourne, Victoria, Australia
Occupations	Documentary film director Producer

Ian David Darling AO is an Australian documentary film director, producer and philanthropist. He is associated with Shark Island Productions and the Shark Island Institute in Sydney, Australia.

Darling's films as director or producer include Alone Across Australia, In The Company of Actors, The Oasis, Paul Kelly - Stories of Me, The Final Quarter and The Pool. He has also worked as an executive producer on films including 2040, The Bleeding Edge, Unrest, On the Record and Paper & Glue.

Outside film production, Darling has held roles with Documentary Australia, Good Pitch Australia, the Sydney Theatre Company and philanthropic organisations. He was appointed an Officer of the Order of Australia in 2018 for service to documentary film production, the performing arts, education, community engagement and social welfare organisations through philanthropy.

=Function Health=

Edits - Some Minor + Recent News

Requesting edits - noting ([WP:COI|COI]]), posting under guidance of my colleague who shared requests here a while ago. Let me know if you need anything, happy to provide. Thank you. SarahSAutumn (talk) 15:09, 17 April 2026 (UTC)

Minor Edits

• Total # of tests is now 160 (currently says 100 in intro) - https://www.nytimes.com/2026/01/08/well/function-health-blood-tests.html

• Company named on 2025 Lists for Inc’s Best in Business and LinkedIn’s Top Startups - https://www.linkedin.com/pulse/linkedin-top-startups-2025-50-us-companies-rise-linkedin-news-hox6f

https://www.geekwire.com/2025/linkedins-list-of-top-50-u-s-startups-includes-three-emerging-companies-from-seattle-area/

Recent News - Drafted some page copy below, if helpful

• January 2026 - Function Health partnered with Sweetgreen, for a limited-time five item menu developed under guidance of co-founder and chief medical officer, Dr. Mark Hyman.

https://www.goodhousekeeping.com/health/diet-nutrition/a69927471/sweetgreens-doctor-designed-menu/ https://www.restaurantbusinessonline.com/food/sweetgreen-taps-longevity-expert-latest-collab

• February 2026 - Function Health partnered with Erewhon Market for a limited edition smoothie. https://www.glossy.co/beauty/wellness/function-healths-new-erewhon-smoothie-was-designed-to-highlight-nutritional-gaps-and-promote-telehealth-lab-testing/

• April 2026 - Function Health acquired Getlabs, a mobile healthcare company that provides at-home diagnostic health testing.

https://www.modernhealthcare.com/mergers-acquisitions/mh-function-health-getlabs-acquisition/ https://pulse2.com/function-health-acquires-getlabs-to-expand-at-home-testing-access/ SarahSAutumn (talk) 15:09, 17 April 2026 (UTC)

Let me know if any more information is required @WhatamIdoing @FeldBum I saw you made edits on the page recently, can you take a look at the above? SarahSAutumn (talk) 21:06, 23 April 2026 (UTC)

I updated the number of tests.

I did not update the claims about Inc's Best in Business and LinkedIn's Top Startups because they sound like minor awards, and listing minor awards is promotional content. WhatamIdoing (talk) 19:05, 24 April 2026 (UTC)

I added the partnerships and acquisitions, with some edits. I think I should mark this as done --FeldBum (talk) 14:01, 30 April 2026 (UTC)

@WhatamIdoing@FeldBumThanks for the review. For 2025 lists, I saw both of these annual awards mentioned on Inc mag + LinkedIn's wikis so I thought they were considered major vs. minor. Have a few more edits but I'll post separately in a bit.SarahSAutumn (talk) 14:23, 1 May 2026 (UTC)

Additional Edits

Requesting some more edits re: recent company news noting COI. Thank you. SarahSAutumn (talk) 15:48, 11 May 2026 (UTC)

• November 2025 - Function Health launched a generative LLM AI chatbot called the Medical Intelligence Lab. The chatbot was developed to provide personalized responses based on user data, wearables, lab results, doctor’s notes, and scans, which was developed under HIPAA standards, such as user encryption.

https://techcrunch.com/2025/11/19/function-health-closes-298m-series-b-at-a-2-5b-valuation-launches-medical-intelligence/ https://insider.fitt.co/function-raises-298m-hits-2-5b-valuation/

•  Done with edits, in a new section

• January 2026 - OpenAI announced the launch of ChatGPT Health, a dedicated tab for user health-care inquiries that would have connectivity to the Function Health app.

https://time.com/7344997/chatgpt-health-medical-records-privacy-open-ai/ https://www.vogue.com/article/what-chatgpt-health-means-for-the-wellness-industry

•  Done with edits, in a new section

• January 2026 - Function Health created a connector with Anthropic that allowed users of Claude to receive personalized responses through the LLM’s access to the user’s health and lab result data.

https://fortune.com/2026/01/11/anthropic-unveils-claude-for-healthcare-and-expands-life-science-features-partners-with-healthex-to-let-users-connect-medical-records/ https://www.businessinsider.com/anthropic-chases-openai-ai-heath-claude-2026-1

•  Done with edits, in a new section

• March 2026 - Function Health announced integrations with Perplexity and Microsoft Copilot

https://longevity.technology/news/perplexity-enters-the-consumer-health-ai-arena/ https://www.business-standard.com/amp/technology/tech-news/perplexity-launches-health-feature-with-apple-health-fitbit-integration-126032000326_1.html https://www.wsj.com/tech/ai/microsofts-new-ai-health-tool-can-read-your-medical-records-and-give-advice-d731f883

•  Done with edits, in a new section

• March 2026 - Katy Perry and Justin Trudeau used Function Health to compare their biological age (notable users) https://www.instyle.com/katy-perry-justin-trudeau-make-joke-about-age-gap-date-night-game-11936593

https://people.com/katy-perry-justin-trudeau-share-playful-moment-on-instagram-11936579

•  Not done as I'm not sure this is notable

• Minor edit to existing line - for better accuracy, can it say that the platform uses AI?

Current line: In May 2025, Function Health acquired Ezra and planned to add Ezra's MRI scanning technology to its platform. https://insider.fitt.co/function-health-acquires-full-body-mri-provider-ezra/

@WhatamIdoing @FeldBum @Mikalra Tagging as you've made previous edits on this page. SarahSAutumn (talk) 15:48, 11 May 2026 (UTC)

Hi @SarahSAutumn, taking a look --FeldBum (talk) 13:59, 26 May 2026 (UTC)

It might make sense to add an AI section under Technology based on these --FeldBum (talk) 14:09, 26 May 2026 (UTC)

Hi @FeldBum, thank you for reviewing. Is there anything for the one marked as Not Done that could be added to the page? Understand if not.

Editors - I left one other update off by accident, if anyone could review: May 2026 - Function Health acquired SuppCo, a platform that provides independent evaluations of dietary supplement trustworthiness. https://longevity.technology/news/function-acquires-suppco-to-add-independent-supplement-testing-and-tracking/ SarahSAutumn (talk) 13:50, 5 June 2026 (UTC)

I'll add that SuppCo acquisition, but I'm on the fence about Katy Perry & Justin Trudeau. Any other editors have any feedback? --FeldBum (talk) 21:18, 5 June 2026 (UTC)

Added the acquisition, with a better citation and some edits. --FeldBum (talk) 21:55, 17 June 2026 (UTC)

Iraqi Jewish Archive

Edit request: mention Voices from the Archive access project

I have a conflict of interest with Voices from the Archive, so I am requesting that uninvolved editors consider two neutral, sourced additions:

1. Add the following sentence to the end of the "Discovery and preservation" section, after the sentence about digitization and online availability:

Subsequent access projects include Voices from the Archive, a JIMENA-fiscally sponsored platform developed by David Breslauer that uses artificial intelligence to generate searchable transcriptions and English translations of the digitized collection.

2. Add the following bullet to the "External links" section:

• Voices from the Archive

Rationale: the article already mentions digitization and online availability, but it does not mention later access tools. These additions are brief, factual, and include both independent coverage and the project site. Davidnbreslauer (talk) 14:56, 11 May 2026 (UTC)

Danna Azrieli

Job title update

Hi editors, Danna Azrieli is no longer chair and is now the permanent CEO of Azrieli Group per this source.

References

I propose adding her title to the infobox.

The second sentence of the introduction should also be updated with the new title. It is also missing a word ("traded"), so I propose changing it to "Azrieli has been CEO of Azrieli Group, a publicly traded real estate company in Israel, since 2025."

Lastly, I suggest updating the Career section to indicate that she was named interim  CEO in 2025 and later permanent CEO in 2026. Maybe something like this at the end of the first paragraph: "Azrieli became acting CEO in 2025, and was permanently appointed to the position in February 2026."

Please let me know what you think. ~~~~ RM Azrieli (talk) 05:40, 10 May 2026 (UTC)

Siblings update

Hi editors, I have a slight error to correct. Danna Azrieli has three siblings: Naomi, Sharon, and Rafi. Could this be updated in the infobox with this source? Thanks! ~~~~ RM Azrieli (talk) 20:14, 16 May 2026 (UTC)

Not done for now: @RM Azrieli, generally we only add family to the infobox if they have their own wikipedia pages, it isn't meant to be a comprehensive list. It is possible Rafi should be added to the biography section, though there are some WP:BLPNAME concerns. I'm not sure how to gracefully add a mention of a brother to the existing text, but you're welcome to suggest a phrasing. Rusalkii (talk) 20:44, 18 June 2026 (UTC)

@Rusalkii: thanks for taking a look. I understand about not wanting to name siblings that don't have their own article. As for adding to the Biography section, what would you think of modifying the second sentence, so it goes from:

::*Azrieli and her sisters, Naomi and Sharon, own 46 percent of the Azrieli Group, a company founded by their father.

to instead something like:

• Azrieli has three siblings; with her sisters, Naomi and Sharon, she owns 46 percent of Azrieli Group, a company founded by their father.

References

Would that work? ~~~~

RM Azrieli (talk) 05:34, 23 June 2026 (UTC)

---

← Previous page Next page→